Chanell Salage
Nurse Practitioner · Knoxville, TNNPI 1275181547
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Sanofi at 52.8% of the total. Reporting peaked in 2021 at $5,319 and has fallen 97.6% since, to $129 in 2025. Among nurse practitioner clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 106 payments — averaging $60.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$3K
- Relievant Medsystems, Inc.$919
- Biogen$406
- EMD Serono, Inc.$379
- Avanir Pharmaceuticals, Inc.$183
- Novartis$152
- plus $979 from 19 others
What the payments were for
- Consulting fees$2,99647%
- Speaking & faculty fees$791%
- Travel & lodging$5619%
- Food & beverage$2,65842%
- Education$1052%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 12 | $3,379 |
| Relievant Medsystems, Inc. | 7 | $919 |
| Biogen | 10 | $406 |
| EMD Serono, Inc. | 6 | $379 |
| Avanir Pharmaceuticals, Inc. | 10 | $183 |
| Novartis | 8 | $152 |
| Biohaven Pharmaceuticals, Inc. | 9 | $146 |
| Johnson & Johnson | 6 | $129 |
| Medtronic | 2 | $113 |
| AstraZeneca | 4 | $81 |
| Bristol Myers Squibb | 4 | $78 |
| E.r. Squibb & Sons, L.L.C. | 4 | $64 |
| Genentech USA, Inc. | 3 | $51 |
| Teva Pharmaceuticals USA, Inc. | 3 | $50 |
| Amgen(2 entities) | 3 | $42 |
| AbbVie | 3 | $40 |
| Galderma Laboratories, L.p. | 2 | $32 |
| Amneal Pharmaceuticals LLC | 2 | $29 |
| Lilly USA, LLC | 2 | $23 |
| UCB, Inc. | 1 | $22 |
| Mallinckrodt Hospital Products Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $17 |
| Boston Scientific | 1 | $15 |
| Acadia Pharmaceuticals Inc | 1 | $14 |
| Acorda Therapeutics, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,399 in reported general payments places this provider in the 90th percentile of 2,662 nurse practitioner providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tizanidine Hcl | 112 | $420 |
| Gabapentin | 52 | $357 |
| Methylprednisolone | 19 | $153 |
| Meloxicam | 20 | $48 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Knoxville
- Karen RodenKnoxville$265K
- Erica HembreeKnoxville$125K
- Robin LovedayKnoxville$56K
- Tiffany SteelmanKnoxville$21K
- Jennifer BerryKnoxville$19K
- Erica HillKnoxville$13K
- Amy HatcherMurfreesboro$1.1M
- Susan UtleyNashville$194K
- Whitney EricksonMemphis$159K
- Brooke FaughtNashville$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.